Form 4 for CDNA CareDx, Inc.
Accepted 2022-03-11 00:00:00 ET · period of report 2022-03-09 · accession 0001217234-22-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-11 | 2022-03-09 | CDNA | Goldberg Michael | Dir | S - Sale+OE | $33.41 | -500 | 61.3K | -0.8% | -$16.7K |
| D | 2022-03-11 | 2022-03-09 | CDNA | Goldberg Michael | Dir | M - OptEx | $1.22 | +500 | 61.8K | +0.8% | +$610 |
| D | 2022-03-11 | 2022-03-09 | CDNA | Goldberg Michael | Dir | M - OptEx | $0.00 | -500 | 12.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-09 | S | D | 500 | $33.41 | 61,267 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.30 to $33.55, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Common Stock | 2022-03-09 | M | A | 500 | $1.22 | 61,767 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2022-03-09 | M | D | 500 | $0.00 | 12,000 | D | $1.22 · — to 2027-07-13 | 500 Common Stock | (F3) 1/12th of the shares subject to the option vested on August 13, 2017 and the shares subject to the option vested monthly thereafter through July 13, 2018. |